Thanh Nguyen
Pediatric Endocrinology · Jacksonville, FLNPI 1831296656
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Ascendis Pharma Endocrinology Inc at 34.8% of the total. That places this record below the midpoint for pediatric endocrinology clinicians in FL, where the typical reported total is $1,950.
Across 107 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ascendis Pharma Endocrinology Inc$679
- Medtronic$266
- Tolmar Pharmaceuticals, Inc.$219
- Xeris Pharmaceuticals, Inc.$87
- Novo Nordisk$77
- Insulet Corporation$73
- plus $549 from 19 others
Across 49 payments — averaging $2643.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$102K
- Boehringer Ingelheim$17K
- Boehringer Ingelheim Pharma GmbH & Co.kg$10K
- Boehringer Ingelheim France S.a.s.$514
What the payments were for
- Food & beverage$1,88196%
- Education$694%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 39 | $679 |
| Medtronic(2 entities) | 3 | $266 |
| Tolmar Pharmaceuticals, Inc. | 28 | $219 |
| Xeris Pharmaceuticals, Inc. | 4 | $87 |
| Novo Nordisk | 4 | $77 |
| Insulet Corporation | 3 | $73 |
| Tolmar, Inc. | 4 | $69 |
| Pfizer | 3 | $51 |
| Bsn Medical Inc | 1 | $51 |
| Abbott | 3 | $50 |
| Biomarin Pharmaceutical Inc. | 1 | $44 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Organogenesis Inc. | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Shionogi Inc | 1 | $22 |
| Stryker | 1 | $21 |
| Smith+Nephew | 1 | $21 |
| Biogen | 1 | $21 |
| Coloplast | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Laborie Medical Technologies Corp. | 1 | $16 |
| AbbVie | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Zealand Pharma US, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$133
- Resolute$113
How this compares
$1,950 in reported general payments places this provider in the 50th percentile of 102 pediatric endocrinology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 17 | $130 |
Paid to pharmacies, not to this prescriber.
Other pediatric endocrinology in Jacksonville
- Nelly MaurasJacksonville$17K
- Larry FoxJacksonville$2K
- Jose CanasJacksonville$1K
- Joshua YangOrlando$846K
- Henry RodriguezTampa$211K
- Dorothy ShulmanTampa$104K
- Michael HallerGainesville$102K
- Alejandro DiazMiami$101K
- Samuel FreedmanPembroke Pines$71K
- Jennifer MillerGainesville$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.